This increased expression was found to be significantly correlated with Jak/STAT, NF-κB and IL-2 signalings in our PTCL patient series, suggesting that these pathways could be the responsible for PIM activation and could contribute to PTCL cell survival. The gene discussed is SOAT1; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.